[Nalbuphine versus pentazocine in the period following surgery of the digestive system in patients with cardiovascular disease].
de la Coussaye
J E
JE
Département d'Anesthésie-Réanimation, CHRU, Nîmes.
Eledjam
J J
JJ
Saissi
G
G
Bassoul
B
B
d'Athis
F
F
du Cailar
J
J
D000368:Aged; D002318:Cardiovascular Diseases / Q000150:complications*; D004066:Digestive System Diseases / Q000150:complications / Q000601:surgery*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009019:Morphinans / Q000627:therapeutic use*; D009266:Nalbuphine / Q000627:therapeutic use*; D010149:Postoperative Pain / Q000188:drug therapy*; D010423:Pentazocine / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D009019:Morphinans; D009266:Nalbuphine; D010423:Pentazocine
Nalbuphine versus pentazocine en postopératoire de chirurgie digestive chez des sujets porteurs d'une affection cardiovasculaire.